文献速递前列腺癌

磁共振成像靶向前列腺穿刺活检的局部麻醉经会阴路径

Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2017-05-09

研究在三级转诊中心纳入181例连续男性,于2014年9月至2016年1月接受局部麻醉经会阴磁共振成像靶向前列腺穿刺活检,评估不良事件、疼痛评分及临床显著前列腺癌检出率。结果显示无脓毒症或再入院,中位视觉模拟疼痛评分为1.0,92%的男性会推荐该操作,临床显著癌检出率为57%和71%(分别按UCL定义1和2)。

要点

  • 181例男性243个病灶接受局麻经会阴MRI靶向穿刺,无脓毒症或再入院。
  • 中位视觉模拟疼痛评分为1.0,23/25(92%)男性会向他人推荐该操作。
  • UCL定义1癌检出104/181(57%),UCL定义2癌检出129/181(71%)。

核心结论

  • 该局部麻醉经会阴MRI靶向前列腺穿刺活检方法可行、可耐受,并可在门诊环境中进行。

研究设计与样本

  • 三级转诊中心连续纳入181例男性,于2014年9月至2016年1月接受局部麻醉经会阴MRI靶向前列腺穿刺活检,共243个病灶。
  • 采用标准化局部麻醉技术,通过视觉估测获取靶向穿刺,靶向穿刺针数由多名操作者各自决定。
  • 评估不良事件、患者视觉模拟疼痛评分及临床显著癌检出率(按UCL定义1和2,以及分别按优势和非优势Gleason 4模式存在),次要评估任何癌检出、按MRI Likert评分和就诊PSA的检出率,差异用卡方检验(P<0.05)。

主要发现

  • 无脓毒症发作或再入院,1例操作因患者不适而中止。
  • 25例男性中23例(92%)会向他人推荐该操作;中位视觉模拟疼痛评分为1.0(四分位距:0.0-2.4)。
  • 104/181(57%)患有UCL定义1疾病(Gleason ⩾4+3和/或最大癌长度⩾6 mm),129/181(71%)患有UCL定义2癌症(Gleason ⩾3+4和/或最大癌长度⩾4 mm)。
  • 54/181(30%)和124/181(69%)分别患有优势和非优势Gleason 4模式或更高级别疾病(不论癌长度)。
  • 任何癌检出142/181(78%);显著疾病在更高MRI评分病灶和PSA⩾10 ng ml-1的男性中更可能被检出。

关键数值与推荐

  • 临床显著癌按UCL定义1:Gleason ⩾4+3和/或最大癌长度⩾6 mm;UCL定义2:Gleason ⩾3+4和/或最大癌长度⩾4 mm。
  • 任何癌检出定义为142/181(78%)。
  • 显著疾病在更高MRI评分病灶和PSA⩾10 ng ml-1的男性中更可能被检出。

临床怎么用

  • 作者认为该局部麻醉经会阴MRI靶向前列腺穿刺活检方法可行、可耐受,并可在门诊环境中进行。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite high rates of disease misclassification and sepsis, the use of transrectal biopsy remains commonplace. Transperineal mapping biopsies mitigate these problems but carry increased cost and patient burden. Local anaesthetic, multiparametric magnetic resonance imaging (MRI)-targeted transperineal biopsy may offer an alternative. Here, we aim to determine the feasibility, tolerability and detection rates of clinically significant prostate cancer using a local anaesthetic, transperineal, MRI-targeted biopsy technique. METHODS: Tertiary referral centre in which 181 consecutive men underwent local anaesthetic, transperineal MRI-targeted prostate biopsy (September 2014 to January 2016). A standardized local anaesthetic technique was used to obtain targeted biopsies using visual estimation with the number of targeted cores determined by each of a number of users. We assessed adverse events, patient visual analogue pain scores and detection rates of clinically significant cancer (defined by University College London (UCL) definitions one and two and separately by the presence of dominant and non-dominant Gleason pattern 4). We secondarily assessed detection of any cancer, rates of detection by MRI (Likert) score and by presenting PSA. Differences were assessed using Chi-squared tests (P<0.05). RESULTS: One hundred eighty-one men with 243 lesions were included. There were no episodes of sepsis or re-admissions and one procedure was abandoned owing to patient discomfort. Twenty-three out of 25 (92%) men would recommend the procedure to another. Median visual analogue pain score was 1.0 (interquartile range: 0.0-2.4). A total 104/181 (57%) had UCL definition 1 disease (Gleason ⩾4+3 and/or maximum cancer length ⩾6 mm) and 129/181 (71%) had UCL definition 2 cancer (Gleason ⩾3+4 and/or maximum cancer length ⩾4 mm). Fifty-four out of 181 (30%) and 124/181 (69%) had dominant and non-dominant pattern 4 disease or greater (irrespective of cancer length). Any cancer was detected in 142/181 (78%). Significant disease was more likely in higher MRI-scoring lesions and in men with PSAs ⩾10 ng ml-1. CONCLUSIONS: This approach to prostate biopsy is feasible, tolerable and can be performed in ambulatory settings.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Bass EJ, Donaldson IA, Freeman A, et al. Magnetic resonance imaging targeted transperineal prostate biopsy: a local anaesthetic approach. Prostate Cancer Prostatic Dis. 2017. PMID: 28485391. doi:10.1038/pcan.2017.13

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。